Entities / Company
Armata Pharmaceuticals (United States).
company in Los Angeles, United States
- Reports this week
- 0
- Active events
- 0
- Connections
- 18
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Gone quiet
No new reports in 90+ days-
Innoviva was identified as the largest shareholder of Armata Pharmaceuticals in August 2025.Some support1 report
-
Armata Pharmaceuticals received an upgrade following an upward trend in its earnings estimates.Some support3 reports
-
Armata Pharmaceuticals participated in a conference with H.C. Wainwright on September 4, 2025. Deborah L. Birx was CEO of Armata.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Armata Pharmaceuticals (United States) this week
News at the entities that move Armata Pharmaceuticals (United States) most-
FDA StructuralGeneric medicine services are seeking approval for launch from the FDA.Moves Armata Pharmaceuticals (United States)
-
Incepta Pharmaceuticals Shared contextTilray Brands, Inc.'s stock change lagged the S&P 500 gain on August 28, 2025, while the company holds a Zacks Rank of #3.Moves Armata Pharmaceuticals (United States)
Connections
The 2 strongest of 18, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
FDA Structural
Armata Pharmaceuticals seeks regulatory approval and agreement from the FDA for its pharmaceutical products.
-
Incepta Pharmaceuticals Shared context
Evidence only confirms Armata Pharmaceuticals belongs to a specific industry group, showing no direct coupling with Incepta Pharmaceuticals.
History
Events by the month they beganJune 2026
3 events- Innoviva was identified as the largest shareholder of Armata Pharmaceuticals in August 2025.
- Armata Pharmaceuticals received an upgrade following an upward trend in its earnings estimates.
- Armata Pharmaceuticals participated in a conference with H.C. Wainwright on September 4, 2025. Deborah L. Birx was CEO of Armata.